Trials / Completed
CompletedNCT00913848
To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions
A Single-Dose Comparative Bioavailability Study of Two Formulations of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 21 Years – 47 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Divalproex Sodium 500 mg delayed release tablets under fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Divalproex Sodium 500 mg DR Tablets (Sandoz Inc., USA) | |
| DRUG | Depakote 500 mg DR Tablets (Abbott Laboratories, USA) |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2005-10-01
- Completion
- 2005-10-01
- First posted
- 2009-06-04
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00913848. Inclusion in this directory is not an endorsement.